CN113208976A - Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof - Google Patents

Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof Download PDF

Info

Publication number
CN113208976A
CN113208976A CN202010930378.7A CN202010930378A CN113208976A CN 113208976 A CN113208976 A CN 113208976A CN 202010930378 A CN202010930378 A CN 202010930378A CN 113208976 A CN113208976 A CN 113208976A
Authority
CN
China
Prior art keywords
ganoderma lucidum
fermentation
skin
preparation
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010930378.7A
Other languages
Chinese (zh)
Inventor
王昌涛
张佳婵
李萌
赵丹
王冬冬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Technology and Business University
Original Assignee
Beijing Technology and Business University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Technology and Business University filed Critical Beijing Technology and Business University
Priority to CN202010930378.7A priority Critical patent/CN113208976A/en
Publication of CN113208976A publication Critical patent/CN113208976A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a preparation method of a skin-firming and nourishing ganoderma lucidum composite fermentation product, which comprises the following steps: inoculating the ganoderma lucidum to a fermentation substrate consisting of poria cocos, oat, tremella, grape seed extract and water for fermentation culture, and then performing sterilization treatment to obtain the ganoderma lucidum composite fermentation product. The novel ganoderma lucidum composite fermentation raw pulp is prepared by selecting a suitable ganoderma lucidum strain to carry out composite liquid fermentation on poria cocos, oat bran powder, tremella and grape seed extract, has good skin tightening and nourishing effects, and can be used as a good raw material of a skin tightening and nourishing cosmetic or directly used as a cosmetic.

Description

Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof
Technical Field
The disclosure relates to the technical field of fermentation, in particular to a skin-firming and nourishing ganoderma lucidum composite fermentation product and a preparation method and application thereof.
Background
Poria (Poria cos (Schw.) Wolf), a fungus of the genus Poria of the order Polyporales, has been widely used in traditional Chinese medicine as a medicinal and edible material, and its dried sclerotium has been used as a medicine. The Poria sclerotium contains beta-pachyman 93 wt% and triterpenes such as acetylpachymic acid, pachymic acid, 3 beta-hydroxylanostane trienoic acid, gum, chitin, protein, fat, sterol, lecithin, glucose, adenine, histidine, choline, beta-pachyman decomposition enzyme, lipase, protease, etc. Poria cocos (Poria cocos) extract has a proliferation promoting effect on integrin and the like, the integrin can represent proliferation of fibroblasts and adhesion between cells and between fibrin, and the proliferation of integrin can reduce the diameter and volume of collagen wrapped by fibroblasts, thereby having an astringent effect, and can be used in cosmetics for tightening skin and removing fine lines, and also has antibacterial, anti-inflammatory and moisture-retaining properties.
Oats (Avena sativa L.) are annual herbaceous plants of the genus Avena, of the family poaceae. Oat grains contain oat alkaloids which have various biological activities of oxidation resistance, allergy resistance, proliferation resistance and itching relieving, have certain efficacy on treating coronary heart disease and colon cancer, and are commonly used in products such as emulsion skin care products, after-sun repair, rhinitis spray, infant products for relieving itching of skin, external cream for treating dermatitis and the like. In addition, the oat contains skin brightening peptide, has strong protease activity inhibition, has an antioxidant effect, has a penetration assisting effect, helps the skin to better absorb other nutrient substances, simultaneously conditions the skin, is efficient in moisturizing and reduces the roughness of the skin. The oat firming protein special in the oat bran has the effects of firming skin, moisturizing and resisting aging.
Tremella fuciformis (Tremella fuciformis) is the fruiting body of Tremella fungi. Tremella is a traditional edible fungus, and the active ingredient tremella polysaccharide contained in the tremella is provided with a special health care function. Besides the health care function, the tremella polysaccharide has excellent moisture retention and water locking capacity, good lubricity and film forming property and certain capacity of removing hydroxyl free radicals, so that the tremella polysaccharide is also commonly used in skin care products. Modern skin care products are added with a polysaccharide component which is extracted from tremella fuciformis and has the function of giving a smooth and unique texture like a silk like cream and the like and the effect of moisturizing the skin.
The grape seed extract, the main component of which is procyanidine, is a novel high-efficiency natural antioxidant which can not be synthesized in a human body and is extracted from grape seeds, is one of the most efficient antioxidants from plant sources discovered so far, can effectively remove redundant free radicals in the human body, has the functions of super delaying senescence and enhancing immunity, and has the known main effects of resisting inflammation, histamine and allergy, resisting allergen, resisting oxidation, resisting fatigue, enhancing the physique, improving the sub-health state, delaying senescence, improving dysphoria, irritability, dizziness, hypodynamia, hypomnesis symptoms, beautifying, promoting blood circulation and the like. The grape seed extract is used as main functional component of cosmetic, and has effects of inhibiting tyrosinase activity, scavenging free radicals, reducing melanin deposition and dermatitis, astringing, tightening skin, preventing skin wrinkle, smoothing skin, improving elasticity, and caring skin.
Ganoderma Lucidum (Ganoderma Lucidum Karst) is a fungus of Polyporaceae, contains many chemical components such as ganoderan, triterpenes, nucleosides, sterols, alkaloids, amino acids, microelements, etc., and has biological activities of resisting tumor, protecting liver, regulating immunity, resisting aging, etc., so it has outstanding health promotion value, and is a cosmetic product with effects of resisting wrinkle, diminishing inflammation, and caring skin. Particularly, the ganoderma lucidum polysaccharide which is the active ingredient of ganoderma lucidum can effectively inhibit the formation of free radicals, resist oxidation and aging, increase the original collagen of skin, effectively promote the formation of hyaluronic acid, keep the skin tender and lusterless and keep the optimal state. The ganoderma lucidum is specified in the pharmacopoeia as the dry fruiting body of ganoderma lucidum or ganoderma sinensis, so the fruiting body is the main medicinal part applied in traditional Chinese medicine and health products. In the nineties, the spore powder of the ganoderma lucidum is found to have better pharmacological activity, and along with the great improvement of the yield of the spore powder, the application of the ganoderma lucidum spore powder in health-care products exceeds that of sporocarp. Meanwhile, the ganoderma lucidum fermentation mycelium has the advantages of stable quality, high yield and the like, and is increasingly applied to product development. Researches show that 3 materials of ganoderma lucidum sporocarp, spore powder and mycelium have similar effects of resisting tumor, regulating immunity and the like, but the content and the types of polysaccharide are different.
At present, the more common active substance extraction methods in the fields of food and cosmetics comprise a hot water extraction method, an acid extraction method, an alkali extraction method, an enzyme extraction method and a microbial fermentation method. The microbial fermentation method does not need to add other catalysts, only needs to culture a large number of microbial strains, and then adds a substrate to carry out reaction, so that the microbial method is more specific and effective than a chemical reagent reaction method; the reaction condition is mild, the microbial fermentation is generally carried out under the conditions of normal temperature and pH of about 7, and harsh conditions such as high temperature, high pressure and the like are not needed; the operation of the equipment is simple and safe, the produced public hazard is less, the environmental pollution is not caused generally, and the post-treatment is relatively simple; the conversion rate can be improved by screening different strains and optimizing reaction conditions, the strains for carrying out microbial conversion on the same substrate can be various, and the optimal strains can be selected by screening, so that the higher conversion rate can be ensured. At present, many researchers at home and abroad adopt a biological method to produce polysaccharide, namely, a microbial method, an enzymatic method, plant cell tissue culture and other multiple biological transformation methods are combined, and the obvious advantages are presented. Microbial fermentation technology plays an increasingly important role in the research and development of natural active substances. The application of fermentation technology in skin care products has been reported in a large number, and the most notable example is SK II Shenxian water.
Although poria cocos, oat, tremella, grape seed extract and ganoderma lucidum are applied in the field of cosmetics, poria cocos, oat, tremella, grape seed extract and ganoderma lucidum are basically compounded with various raw materials, the extraction modes of active matters are various, and the problem of improving the extraction effect of the active matters by selecting more potential material combinations still remains to be faced by researchers.
Disclosure of Invention
The following presents a simplified summary of the disclosure in order to provide a basic understanding of some aspects of the disclosure. It should be understood that this summary is not an exhaustive overview of the disclosure. It is not intended to identify key or critical elements of the disclosure or to delineate the scope of the disclosure. Its sole purpose is to present some concepts in a simplified form as a prelude to the more detailed description that is discussed later.
In view of the above defects of the prior art, the present disclosure aims to provide a skin-firming and nourishing ganoderma lucidum composite fermentation product, a preparation method and an application thereof, which have good skin-firming and nourishing effects.
According to one aspect of the disclosure, a preparation method of a skin-firming and nourishing ganoderma lucidum composite fermentation product is provided, which comprises the following steps: inoculating the ganoderma lucidum to a fermentation substrate consisting of poria cocos, oat bran, tremella, grape seed extract and water for fermentation culture, and then performing sterilization treatment to obtain the ganoderma lucidum composite fermentation product.
The poria cocos adopted in the present disclosure is a dried poria cocos mass, the extract of which has a proliferation promoting effect on integrin and the like, the integrin can reflect the proliferation of fibroblasts and the adhesion between cells and between fibrin, and the proliferation of the integrin can reduce the diameter and volume of collagen wrapped by fibroblasts, thereby having an astringent effect, and can be used in cosmetics for tightening skin and repairing fine wrinkles, and also has antibacterial properties, anti-inflammatory properties and moisture retention properties. In the embodiment of the disclosure, the poria cocos is preferably used after being crushed; preferably, the amount is 0.01-1%, i.e., Poria is 0.01-1% (e.g., 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, etc.) by weight of water. If the dosage ratio exceeds 1%, the system becomes too viscous after sterilizing the tuckahoe and water, and the oxygen supply is insufficient, thus being not beneficial to microbial fermentation; if the dosage ratio is less than 0.01%, the fermentation can still be smoothly carried out, but the system is too dilute, and the production efficiency is lower.
The oat bran adopted in the method is rich in water-soluble dietary fiber, has the effects of resisting skin allergy, softening blood vessels and the like, has an auxiliary conditioning effect on skin and a blood circulation system, and has the effects of skin tightening, moisture retention, moistening and ageing resistance due to the unique oat firming protein. Oat bran is preferably present in an amount of 0.01-0.2% in embodiments of the disclosure, i.e., the amount of oat bran present in the fermentation substrate is 0.01-0.2% by mass of water (e.g., 0.03%, 0.05%, 0.1%, 0.15%, 0.18%, etc.).
The white fungus is adopted in the disclosure, the extract of the white fungus has an inhibition effect on the activity of collagenase, the extract of the white fungus has a good moisturizing effect, and a certain inhibition effect on skin allergy. The tremella fuciformis used in the embodiment of the disclosure is dry tremella fuciformis powder, and preferably cut-log tremella fuciformis is adopted; preferably, the amount is 0.01-0.5%, i.e. the weight of the tremella fuciformis in the fermentation substrate is 0.01-0.5% (such as 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, 0.45% and the like) of the weight of water. The tremella powder used in the present disclosure can be prepared by, for example, crushing tremella (dried fruit body) by a crusher, and further, for example, crushing tremella (dried fruit body) at a low temperature; also commercially available. Experiments prove that the proper effect cannot be reflected when the tremella is used in a too low dosage ratio, and the viscosity of a fermentation system is possibly too high when the tremella is used in a too high dosage ratio, so that the fermentation is influenced.
The grape seed extract adopted in the disclosure has an inhibitory effect on the aspartic protease-8, the caspase is a core component causing apoptosis, so that the inhibition thereof means prolonging the life of cells, enhancing the activity of skin, having the effect of eliminating free radicals, inhibiting the collagenase and the generation of nitric oxide, and showing the anti-aging ability in many aspects. The grape seed extract used in the embodiments of the present disclosure is preferably used in an amount of 0.01% to 0.05%, i.e., 0.01% to 0.05% by weight of water of the fermentation substrate (e.g., 0.015%, 0.02%, 0.03%, 0.04%, 0.045%, etc.). More preferably, the grape seed extract is extracted at a ratio of 4-20:1 (e.g., 5:1, 8:1, 10:1, 12:1, 15:1, 18:1, etc.), i.e., 1 part extract is obtained from 4-20 parts of grape seed material. The grape seed extract can be purchased from the market or prepared by itself, for example, 1 part by weight of the extract is obtained by hot water extraction from 4 to 20 parts by weight of the grape seed material. The grape seed extract cannot reflect the corresponding effect when the dosage ratio is too low, and the fermentation liquor obtained when the dosage ratio is too high has darker overall color, is hyperpigmented on the skin and is easy to cause skin anaphylactic reaction.
In the fermentation substrate, the poria cocos, the oat bran, the tremella and the grape seed extract are added into water and then are subjected to sterilization treatment to prepare the fermentation substrate.
The fermentation bacteria adopted in the method are ganoderma lucidum, secondary metabolites in the ganoderma lucidum are more than 430, and the ganoderma lucidum mainly contains active ingredients such as ganoderma lucidum polysaccharide, triterpenoids, proteins and the like, and has high medicinal value and pharmacological action such as immunoregulation, antivirus, anti-tumor, blood fat reduction and the like; the active ingredients such as ganoderan, terpenoid and phenols in Ganoderma have antioxidant and free radical scavenging effects; ganoderma can also inhibit the growth of helicobacter pylori, Escherichia coli, Staphylococcus aureus, etc., wherein ganoderan plays an important role. The Ganoderma extract has effects of promoting the generation of collagen and ceramide, enhancing skin cell metabolism, resisting wrinkle, and resisting aging; has activating effect on luciferase and shows anti-inflammatory effect; has inhibitory effect on tyrosinase, and can whiten skin, and has good whitening effect by combining with its moisture-retaining ability. The applicant finds out through screening experiments that the Ganoderma lucidum liquid culture is carried out on the raw material formula disclosed by the invention, preferably, the Ganoderma lucidum (Ganoderma lucidum) strain wG055 with the preservation number of CGMCC No.17789 is adopted.
Preferably, the mycelium volume percentage of the ganoderma lucidum liquid for inoculating to the fermentation substrate is more than 80% (such as 85%, 90%, 95%, 100% and the like); the inoculation ratio of the ganoderma lucidum, namely the volume ratio of the bacterium liquid to the fermentation substrate is 1-10% (such as 1.5%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 9.5% and the like).
Further, the preparation method of the bacterial liquid of the Ganoderma lucidum (Ganoderma lucidum) strain wG055 sequentially comprises the following steps:
and (3) activation: inoculating the strain to a culture medium of glucose potato agar for activation, wherein the preservation number of the strain is CGMCC No.17789, and the activation temperature is 23-28 ℃, and the activation time is 3-7 d;
liquid culture: inoculating the single colony 2-3 rings obtained in the activation step into 100mL of glucose potato liquid culture medium for culture at the temperature of 23-28 ℃ for 3-7d at the rotation speed of 160-200rpm to obtain the bacterial liquid of the Ganoderma lucidum (Ganoderma lucidum) strain wG055 for inoculation.
In the above method for preparing the skin-firming and nourishing ganoderma lucidum composite fermentation product, as a preferred embodiment, the temperature of the fermentation culture is 25-30 ℃ (for example, 25.5 ℃, 26 ℃, 27 ℃, 28 ℃, 29 ℃, 29.5 ℃ and the like) and the time is 3-7d (for example, 3.5 days, 4 days, 5 days, 6 days, 6.5 days and the like), and the stirring treatment is carried out during the fermentation culture; more preferably, the rotation speed of the stirring treatment is 100-200rpm (such as 110rpm, 120rpm, 130rpm, 140rpm, 150rpm, 160rpm, 170rpm, 180rpm, 190rpm, etc.).
In the above method for preparing the skin-firming and nourishing ganoderma lucidum composite fermentation product, as a preferred embodiment, the temperature of the sterilization treatment after the fermentation culture is 90-121 ℃ (such as 95 ℃, 100 ℃, 105 ℃, 108 ℃, 110 ℃, 115 ℃, 118 ℃, 120 ℃ and the like), and the time is 15-60min (such as 20min, 25min, 30min, 35min, 40min, 45min, 50min, 55min and the like).
In the above preparation method of the skin-firming and nourishing ganoderma lucidum composite fermentation product, as a preferred embodiment, before the sterilization treatment, the separation treatment is further included, the precipitate is discarded, the supernatant is taken for the sterilization treatment, and finally the ganoderma lucidum composite fermentation product, i.e. the ganoderma lucidum composite fermentation raw stock, is obtained.
In the above preparation method of the skin-firming and nourishing ganoderma lucidum composite fermentation product, as a preferred embodiment, the sterilization treatment further comprises separation treatment, discarding the precipitate, taking the supernatant, and finally obtaining the ganoderma lucidum composite fermentation product, i.e. the ganoderma lucidum composite fermentation raw stock.
In the above method for preparing the skin-firming and nourishing ganoderma lucidum composite fermentation product, as a preferred embodiment, the separation treatment is a centrifugation treatment; further preferably, the speed of the centrifugation treatment is 3500-8000r/min (such as 4000r/min, 4500r/min, 5000r/min, 5500r/min, 6500r/min, 7000r/min, 7500r/min, etc.), and the time is 20-60min (such as 25min, 30min, 40min, 50min, 55min, etc.).
In the preparation method of the skin-firming and nourishing ganoderma lucidum composite fermentation product, as a preferred embodiment, the preparation method further comprises drying treatment after the sterilization treatment, and finally obtaining the ganoderma lucidum composite fermentation product, namely the ganoderma lucidum composite fermentation dry powder.
In the above method for preparing the skin-firming and nourishing ganoderma lucidum composite fermentation product, as a preferred embodiment, the drying treatment may be spray drying, vacuum freeze drying, or the like.
According to still another aspect of the disclosure, the ganoderma lucidum composite fermented dry powder prepared by the preparation method is also provided.
According to another aspect of the disclosure, the ganoderma lucidum composite fermentation protoplasm prepared by the preparation method is also provided.
According to another aspect of the disclosure, the application of the ganoderma lucidum composite fermented dry powder in preparing cosmetics is further provided.
According to another aspect of the disclosure, the application of the ganoderma lucidum composite fermentation protoplasm in preparing cosmetics is further provided.
The cosmetic can be facial mask, essence or toner.
According to the technical scheme of the embodiment of the disclosure, the poria cocos, the oat bran, the tremella and the grape seed extract are subjected to composite liquid fermentation by selecting the suitable ganoderma lucidum strain, so that the novel ganoderma lucidum composite fermentation raw pulp is prepared, is safe and non-allergenic, has good moisturizing and oxidation resistance, has good skin firming and nourishing effects, and can be used as a good raw material of skin firming and nourishing cosmetics or directly used as cosmetics.
The preservation date of the ganoderma lucidum strain used in the disclosure is 6 months and 5 days in 2019, the preservation number is CGMCC No.17789, and the classification and the name are as follows: ganoderma (Ganoderma lucidum) strain wG055, the name of the preservation unit is China general microbiological culture Collection center (CGMCC for short), the address is: the western road No.1 Hospital No. 3, Kyoho, Beijing, is assigned a zip code of 100101.
These and other advantages of the present disclosure will become more apparent from the following detailed description of the preferred embodiments of the present disclosure when taken in conjunction with the accompanying drawings.
Drawings
The disclosure may be better understood by reference to the following description taken in conjunction with the accompanying drawings. The accompanying drawings, which are incorporated in and form a part of this specification, illustrate preferred embodiments of the present disclosure and, together with the detailed description, serve to explain the principles and advantages of the disclosure. Wherein:
FIG. 1 is a graph showing the variation trend of the moisture content of skin (abbreviated as "water content") in different time points after use and before use in different areas, when the skin firming nourishing Ganoderma lucidum composite fermentation protoplasm prepared in example 1 is prepared into 10% by volume of aqueous solution (10% sample, i.e. 5# sample) and 0.1% by volume of hyaluronic acid aqueous solution (0.1% HA) for skin moisture content test;
FIG. 2 is a graph showing the median change trend of moisture content in different regions at different time points, when skin moisture content (abbreviated as "water content") is measured by using the original composite fermented pulp of skin firming and nourishing Ganoderma lucidum prepared in example 1 to prepare 10% by volume of aqueous solution (10% sample, i.e. 5# sample) and 0.1% by volume of hyaluronic acid aqueous solution (0.1% HA);
FIG. 3 is a graph showing the variation of the TEWL value at different time points and before use in different areas after use, which is the result of the skin water loss (i.e. percutaneous water loss, abbreviated as "water dispersion") test performed on the skin water loss amount (i.e. percutaneous water loss) test using the skin firming and nourishing Ganoderma lucidum composite fermentation protoplasm prepared in example 1 and prepared into 10% by volume aqueous solution (10% sample, 5# sample) and 0.1% by volume hyaluronic acid aqueous solution (0.1% HA);
FIG. 4 shows the results of skin water loss (i.e. percutaneous water loss, abbreviated as "water dispersion") tests using the skin firming and nourishing Ganoderma lucidum composite fermentation protoplasm prepared in example 1, which is prepared into 10% by volume aqueous solution (10% sample, i.e. sample No. 5) and 0.1% by volume hyaluronic acid aqueous solution (0.1% HA), and shows the median change trend of TEWL values in different areas at different time points.
Detailed Description
Exemplary embodiments of the present disclosure will be described hereinafter with reference to the accompanying drawings.
The experimental procedures used in the following examples are all conventional procedures unless otherwise specified.
Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
The grape seed extract in the following examples is a product produced by Jianxi Jiahe Biotech limited, and the extraction ratio is 10: 1.
Oat bran flour in the following examples was obtained from the commercial farm by-products of the Hoodia city, Bozhou, Anhui province, Inc.
In the following examples, the tremella fuciformis is basswood tremella fuciformis, the brand is October rice field, and crushing treatment is carried out before use.
The poria cocos in the following examples is a dried poria cocos block produced by agriculture and sideline products purchasing limited of Hoodia city, Bozhou, Anhui province, and is subjected to a pulverization treatment before use.
The fermentation bacteria in the following embodiments are Ganoderma lucidum, specifically Ganoderma lucidum (Ganoderma lucidum) strain wG055 with preservation number of CGMCC No.17789, and are obtained from biotransformation laboratory of chemical and material engineering college of Beijing university.
Example 1 preparation of skin firming and nourishing Ganoderma lucidum composite fermentation protoplasm
1. Preparing ganoderma lucidum liquid: inoculating the ganoderma lucidum strain with the preservation number of CGMCC No.17789 to a glucose potato agar culture medium, culturing at 28 ℃ for 7d, activating, then inoculating the obtained single colony to 100mL of glucose potato liquid culture medium, and culturing at 28 ℃ and 180rpm for 7d to obtain ganoderma lucidum liquid, wherein the volume of the mycelium accounts for 80% of the volume of the ganoderma lucidum liquid.
2. Preparing a fermentation substrate: adding Poria 4g, oat bran powder 0.6g, Tremella 1.5g, and grape seed extract 0.2g into 500g water, and sterilizing at 121 deg.C for 20min to obtain fermentation substrate; wherein, the tuckahoe accounts for 0.8 percent, the oat bran powder accounts for 0.12 percent, the tremella accounts for 0.3 percent, and the grape seed extract accounts for 0.04 percent.
3. Obtaining ganoderma lucidum composite fermentation raw pulp: inoculating 15mL of the ganoderma lucidum liquid obtained in the step 1 into 500g of fermentation substrate (about 500mL) to obtain a fermentation system; fermenting the fermentation system in an incubator at 30 ℃ at the rotating speed of 200rpm for 4 days to obtain a fermentation product; centrifuging the fermentation product at 5000r/min for 30min, removing precipitate, collecting supernatant, sterilizing at 115 deg.C for 20min to inactivate bacteria, and obtaining sterilized fermentation product, namely skin firming and nourishing Ganoderma lucidum composite fermentation raw stock.
The appearance of the skin-firming and nourishing ganoderma lucidum composite fermentation raw stock prepared in the embodiment 1 is semitransparent yellow to light brown liquid, the pH value is 4.1-6.3, the viscosity is avoided, the content of soluble solid is 1.5-5.0%, the total number of colonies is less than 50CFU/ml, and no pathogenic bacteria are detected. According to the cosmetic hygiene standard GB7916-87, the total number of bacteria in the cosmetic is not higher than 1000CFU/ml, so that the fermented extract meets the quality requirement of the cosmetic.
Performing component analysis on the skin-firming and nourishing ganoderma lucidum composite fermentation raw stock, wherein a protein detection method refers to GB5009.5-2010, a crude polysaccharide detection method refers to GB/T5009.8-2008, a flavone detection method refers to GB/T5009.124-2003, and a total phenol detection method refers to GB/T8313-2008; the results obtained were as follows: the compound fermentation raw stock prepared in the embodiment 1 contains 0.983g/kg of protein, 4.984g/kg of crude polysaccharide, 0.031g/kg of total flavone (counted by rutin) and 0.025g/kg of total phenol.
Example 2 application of skin-firming and nourishing ganoderma lucidum composite fermentation protoplasm as cosmetic
Safety detection of skin-firming and nourishing ganoderma lucidum composite fermentation raw stock
The human body patch test is mainly used for detecting the irritation of the final cosmetic product or raw materials. The present disclosure performed a closed patch test on the complex fermented raw stock obtained in example 1 according to the cosmetic hygiene code (2015) in order to evaluate its potential skin irritation.
1. Test subjects:
according to the requirements of 'cosmetic contact dermatitis diagnostic standard and treatment principle', the selected test subject cannot participate in the test, and the test subject and the person with high physique sensitivity who have scars, nevus flammeus and other influences on the result judgment at the part to be tested of the skin cannot participate in the test. Suitable volunteers 30 were selected as subjects in this trial, and were randomly selected in the age range of 18-60 years.
2. The test method comprises the following steps:
0.02mL to 0.025mL of a liquid sample (100% ganoderma lucidum composite fermentation protoplasm without dilution) is dripped on a filter paper sheet, and then the filter paper sheet is placed in a spot tester. A blank control (water) was set for each sample and an equal amount of sample solvent distilled water was added to the control cuvette well. The test period lasted 24 h. In order to ensure the accuracy, credibility and scientificity of test results, the volunteers cannot remove the spot tester or make the tested part contact water according to the requirements during the test. After 24h, the plaque tester is removed, and after standing for 30min (waiting for the indentation to disappear), the skin reaction is observed for 24h and 48 h. The grading standard of adverse skin reactions in the human patch test is shown in Table 1.
TABLE 1 grading Standard of adverse skin reactions
Figure BDA0002669999450000091
3. And (3) test results:
see table 2. As can be seen from the table: the ganoderma lucidum composite fermentation raw pulp obtained in the embodiment 1 is used for negative reaction, which shows that the ganoderma lucidum composite fermentation raw pulp provided by the invention has safety and does not bring adverse reaction to human bodies.
TABLE 2 Patch test of Ganoderma lucidum composite fermentation broth obtained in example 1
Figure BDA0002669999450000101
Second, water content and water dispersion test of skin-firming and nourishing ganoderma lucidum composite fermentation raw pulp
The moisturizing effect of the ganoderma lucidum composite fermentation raw stock obtained in example 1 is tested, specifically, skin moisture content test and skin moisture loss test, Hyaluronic Acid (HA) is generally considered as a positive control sample with a good moisturizing effect, and a comparison experiment is performed by using 10% ganoderma lucidum composite fermentation raw stock (marked as sample # 5, namely, an aqueous solution with a volume concentration of 10% prepared from the composite fermentation raw stock prepared in example 1) and 0.1% hyaluronic acid (marked as 0.1% HA, namely, an aqueous solution with a volume concentration of 0.1% prepared from hyaluronic acid).
1. And (3) testing environment: the temperature is 22 +/-1 ℃; humidity is 50-60%.
2. Test area: skin moisture content test, skin moisture loss test: the left and right forearms.
3. Testing time points: skin moisture content test, skin moisture loss test: before use, 5min, 20min, and 60min after use.
4. An experimental instrument: cornemeter, CM825, Tewameter, TM 300.
5. The test method comprises the following steps:
1)30 eligible volunteers participated in the test. The test place has no direct light and no wind, the room temperature is 22-24 ℃, and the humidity is 40-60%. Before detection, cleaning forearms of both sides with facial cleanser, standing for 30min, taking inner side of forearms of the subject, and drawing normal skin with area of 3.5 × 3.5cm with marking pen. The skin moisture content and the amount of skin moisture loss before use were measured in this order.
2) Cutting the facial mask soaked with the sample to be tested (5 # sample, 0.1% HA) into 3 × 3cm size, respectively, sticking on the corresponding mark of forearm, taking down after 15min, lightly soaking the un-dried essence on the test part with cosmetic cotton, and timing.
3) The water content and TEWL value of stratum corneum of 3 parts are tested at 5min, 20min and 60min respectively. Each site measurement was averaged 3 times.
6. And (3) testing results:
FIG. 1 is a graph showing the trend of the percentage change of the water content of the sample No. 5 and 0.1% HA, and FIG. 2 is a graph showing the median change of the water content of the sample No. 5 and 0.1% HA. As can be seen from the figure, the median water content of 5# sample and 0.1% HA reached the maximum 5min after use, and the median water content of 5# sample and 0.1% HA showed a decreasing trend as the time after use was prolonged; after 20min, the percent change in water content for 0.1% HA was less than 0, and the percent change in water content for the 5# sample was about 0, indicating that the water content at this time point after 0.1% HA was below the background data, while the water content at this time point after the 5# sample was still equivalent to the background data; after 60min, the median of the water content of the 5# sample and the 0.1% HA both continued to exhibit a decreasing trend, the percentage change of the water content of the 0.1% HA was below 0, indicating that the water content at this time point after use was below the background data, while the percentage change of the water content of the 5# sample was still about 0, indicating that the water content at this time point was still equivalent to the background data; it can be seen that the sample No. 5 HAs better moisturizing and moisture retention properties than 0.1% HA.
Fig. 3 is a graph showing the variation of percentage change in transdermal water loss of 5# sample and 0.1% HA, and fig. 4 is a graph showing the variation of median transdermal water loss of 5# sample and 0.1% HA. As can be seen from the figure, the change law of the percutaneous water loss of the 5# sample and the 0.1% HA is different, and both reach the maximum 5min after the use, but the TEWL value of the 5# sample is lower than that of the 0.1% HA; the TEWL values of the 5# sample at 20min, 60min after use substantially corresponded to the TEWL values at 5min after use, but for the TEWL value of 0.1% HA, the TEWL values decreased rapidly at 20min after use, and the percentage change in TEWL for the 60min 5# sample and 0.1% HA was greater than 0, indicating that the TEWL at this time point was above the skin background due to the absence of further application of moisture-locking components (e.g., oil).
Therefore, the ganoderma lucidum composite fermentation raw pulp prepared in the embodiment 1 has good water replenishing and moisture preserving performances.
Third, in vitro antioxidant free radical scavenging performance test
1. Experimental methods
Preparing ABTS working solution: 5mL of a 7mmol/L aqueous LABTS solution and 88. mu.L of a 140mmol/L potassium persulfate solution were mixed and left to stand overnight at room temperature in the absence of light to form an ABTS. + stock solution. Before use, the solution is diluted into a working solution by absolute ethyl alcohol, and the absorbance of the working solution at 734nm is 0.70 +/-0.02.
And (3) sample determination: adding 40 μ L of the solution to be detected into 4mL of ABTS working solution, accurately oscillating for 30s, and measuring the absorbance A at 734nm wavelength after 6min reactionSample (I). The clearance was calculated as follows:
ABTS clearance/% (1-A)Sample (I)/0.700)×100。
2. Results of the experiment
The results of the antioxidant scavenging free radical test are shown in table 3. The sample solution to be tested is a ganoderma lucidum composite fermentation raw stock aqueous solution with the volume concentration of 50% and 100% prepared in advance, and a supernatant (as a sample before fermentation) obtained after substrate sterilization in the same proportion as that in example 1. As can be seen from Table 3, the Ganoderma lucidum composite fermentation broth prepared in example 1 has good antioxidant property.
TABLE 3 antioxidant scavenging free radical test results
Figure BDA0002669999450000121
Fourth, tyrosinase inhibition assay
1. Experimental methods
Configuration: 0.1M HCl; PBS solution (pH 6.8, 0.1 mol/L); l-tyrosine solution (0.05g dissolved in 35ml of 0.1mol/L HCl, and the volume is 100ml by PBS (0.1mol/L) buffer solution with the pH value of 6.8); sample solutions (i.e. supernatant of non-inoculated fermentation after substrate sterilization and ganoderma lucidum composite fermentation protoplasm prepared in example 1) in the same proportion as example 1.
The biochemical reaction was carried out in glass test tubes, and the required PBS buffer (pH 6.8, 0.1mol/L), sample solution, L-tyrosine solution were added to each tube according to the data in Table 4 below. Reacting in 37 deg.C water bath for 10min, adding tyrosinase (with enzyme activity of 100U/mL), reacting in 37 deg.C water bath for 10min, and measuring absorbance at 475 nm.
TABLE 4
Reagent C1(ml) C0(ml) T1(ml) T0(ml)
PBS 2 2.5 1 1.5
Sample (I) 0 0 1 1
L-tyrosine 1 1 1 1
Tyrosinase enzyme 0.5 0 0.5 0
The formula for calculating the tyrosinase inhibition rate is as follows:
IR(%)=[(C1-C0)-(T1-T0)]/(C1-C0)×100%
in the formula: IR-sample to OH. clearance; c1-absorbance value of blank control; c0-blank absorbance values without tyrosinase; t is1-sample set absorbance values; t is0-absorbance values of sample sets without tyrosinase.
2. Results of the experiment
The tyrosinase inhibition rate of the supernatant which is not inoculated and fermented after the substrate is sterilized in the same proportion as that of the example 1 is 20.14% + -2.21%, the tyrosinase inhibition rate of the ganoderma lucidum composite fermentation raw pulp prepared in the example 1 is 51.27% + -3.17%, while the vitamin C is adopted as a control, the tyrosinase inhibition rate of 0.1mg/mL vitamin C is 58.82%, the tyrosinase inhibition rate of 0.3mg/mL vitamin C is 64.71%, and the tyrosinase inhibition rate of 1.2mg/mL vitamin C is 70.59%; the ganoderma lucidum composite fermentation raw pulp prepared in the embodiment 1 has good tyrosinase inhibition capability and good whitening effect.
Cell MTT proliferation assay
Human skin fibroblasts are the main structural components constituting the dermis of the skin, can synthesize and secrete extracellular matrixes such as collagen fibers, elastic fibers, reticular fibers, hyaluronic acid and the like, have important effects on maintaining the strength and elasticity of the skin, repairing injuries and beautifying the skin, are the determining factors for maintaining the young state of the skin and are also important components for maintaining the stable structure of the skin. Human skin fibroblasts (HDF-n, from ScienCell) used in this experiment were tested for toxicity to cells.
1. The experimental steps are as follows:
inoculating cells into a 96-well plate, performing overnight synchronization treatment, and performing incubation culture for 24h by using a solution to be tested (namely, a supernatant which is not fermented after the substrate is sterilized in the same proportion as in example 1 and the ganoderma lucidum composite fermentation raw stock prepared in example 1 are respectively diluted into solutions with volume concentration of 5% by using a cell culture solution DMEM); after the culture is finished, replacing a new culture medium, counting MTT0.5g/L, removing the culture medium after 4h, washing the culture medium for three times by PBS, and adding 400 mu L DMSO to fully crack cells; OD was measured at 490nm using a microplate reader. Each experiment was repeated three times. The survival rate of the cells in the control group was 1, and the survival rate of the cells in the other groups was OD490Experimental group/OD490Control group
2. Results of the experiment
The experimental results are shown in Table 5, and it can be seen from the table that the cell survival rate of the 5% concentration group after fermentation is higher than that of the blank control, which indicates that the sample after fermentation has the effect of promoting proliferation of cells.
TABLE 5
Experiment grouping Blank control 5% concentration before fermentation 5% concentration after fermentation
Cell survival rate 1 0.78±0.02 1.24±0.10
Sixth, collagen content determination experiment
1. Experimental methods
Sample preparation: 1) cell blank: pure DMEM; 2) 5% before fermentation: preparing the supernatant which is not fermented after the substrate is sterilized according to the same proportion as that of the example 1 into a solution with the volume concentration of 5 percent by using a DMEM medium; 3) 5% after fermentation: sterilizing, inoculating, culturing and centrifugally sterilizing the substrate in the same proportion to obtain a fermentation sample, namely fermentation raw stock prepared in the embodiment 1, and preparing a solution with the volume concentration of 5% by using a DMEM (DMEM) culture medium; 4) positive control: ascorbyl glucoside was formulated in a 1% by volume solution with DMEM.
Collecting human skin fibroblasts (HDF-n, from ScienCe) in good log phasell company), trypsinized, the digestion was stopped by complete medium, and counted; adjusting the cell concentration of the cell suspension to 1X 105One/ml, and added to 6-well plates, 1ml of fresh complete medium, 1ml of cell suspension, at 37 ℃ in 5% CO per well2Culturing in an incubator overnight; the medium was aspirated, 2ml of each sample was added to each well, 2ml of basal medium was added to the cell control wells, and the mixture was incubated at 37 ℃ with 5% CO2Culturing in an incubator for 48 h. The cell supernatant was collected using a sterile 1.5mL centrifuge tube, centrifuged at 3000 rpm for about 2000-. The light absorption value (OD value) of the supernatant is detected by adopting a human type I Collagen (COLI) enzyme-linked immunoassay kit provided by Nanjing institute of built bioengineering.
2. Collagen content measurement results
The collagen concentration was calculated using elisa calc, a logistic curve (four parameters) was selected for the fitted model, and the regression equation of the standard curve was calculated using the concentration of the standard and the corresponding OD value. Regression equation y ═ (A-D)/[1+ (x/C)B]+ D, wherein: a is 1.64442; b-0.98920; c-14.91037; d-0.22063; r is2=0.96004。
Based on the OD value of the sample, ELISAcalc was used to calculate the corresponding sample concentration on the regression equation, as shown in Table 6. From table 6, it can be seen that the sample after fermentation has a significant effect of promoting the collagen content of the cells at a concentration of 5% compared with the cell control, and no significant difference compared with the positive control, indicating that the fermentation liquid has a comparable collagen synthesis promoting effect with ascorbyl glucoside.
TABLE 6
Figure BDA0002669999450000151
Comparative example 1 Strain screening
1. Preparation of Rice fermentation broth (samples 1-6)
Inoculating candidate No. 1-6 Ganoderma strains with 1% rice as substrate, culturing at 28 deg.C for 5 days, and centrifuging to obtain supernatant. Test after sterilization and addition of preservative. Among the candidate No. 1-6 Ganoderma strains, No. 1-3 strains are collected from Chuzhou city of Anhui province, No. 4-5 strains are collected from Changbai mountain of Jilin province, No. 6 strains are laboratory-preserved strains, and No.1 strains are Ganoderma strains wG 055.
The specific method comprises the following steps:
1) preparing a seed solution: activating the six ganoderma lucidum strains by using a PDA (personal digital Assistant) plate, transferring single colonies into a potato dextrose water liquid culture medium for amplification culture under the culture condition of 28 ℃ and 180rpm for 5 d.
2) Preparation of samples: adding 3g of rice and 297g of water into a 500ml triangular flask, sterilizing at 121 ℃ for 15min, inoculating 3ml of seed solution, and culturing at 28 ℃ and 180rpm for 5 days; respectively obtaining No. 1-6 rice fermentation liquor, namely samples 1-6. The supernatant of the non-inoculated fermented rice was used as sample No. 0.
Evaluation of ABTS radical scavenging efficacy
Preparing ABTS working solution: 5mL of a 7mmol/L aqueous LABTS solution and 88. mu.L of a 140mmol/L potassium persulfate solution were mixed and left to stand overnight at room temperature in the absence of light to form an ABTS. + stock solution. Before use, the solution is diluted into a working solution by absolute ethyl alcohol, and the absorbance of the working solution at 734nm is 0.70 +/-0.02.
And (3) sample determination: adding 40 μ L of the solution to be detected into 4mL of ABTS working solution, accurately oscillating for 30s, and measuring the absorbance A at 734nm wavelength after 6min reactionSample (I). The clearance was calculated as follows:
ABTS clearance/% (1-A)Sample (I)/0.700)×100。
The results are shown in Table 7, from which it can be seen that sample 1 has the highest ABTS radical scavenging capacity compared to the other samples.
TABLE 7 ABTS test results for rice fermentation broths obtained from different Ganoderma species
Fermentation broth numbering ABTS clearancePercentage ratio%
0 28.95±5.04
1 65.41±2.34
2 60.47±4.25
3 56.24±7.45
4 55.85±0.87
5 57.24±2.47
6 48.69±5.24
3. Skin feel test
The evaluation was performed according to the evaluation criteria (Table A) and the specific scores are shown in Table B, and the overall score for sample 1 was relatively high by the overall analysis.
TABLE A skin feel test evaluation criteria
Figure BDA0002669999450000161
Figure BDA0002669999450000171
Skin feel test results for samples 0-6 in Table B
Figure BDA0002669999450000172
In summary, in the embodiments according to the present disclosure, the present disclosure provides the following technical solutions, but is not limited thereto:
scheme 1, a preparation method of a skin-firming and nourishing ganoderma lucidum composite fermentation product, which is characterized by comprising the following steps: inoculating the ganoderma lucidum to a fermentation substrate consisting of poria cocos, oat, tremella, grape seed extract and water for fermentation culture, and then performing sterilization treatment to obtain the ganoderma lucidum composite fermentation product.
Scheme 2, the preparation method according to scheme 1, wherein in the fermentation substrate, the poria cocos is dry, and the amount of the poria cocos is 0.01-1% of the weight of water; the oat is oat bran powder, and the using amount of the oat bran powder is 0.01-0.2% of the mass of water; the tremella is dry and the amount of the tremella is 0.01-0.5% of the weight of water; the dosage of the grape seed extract is 0.01-0.05% of the weight of water.
The preparation method according to the scheme 3 and the scheme 2, characterized in that the poria cocos and the tremella fuciformis are subjected to crushing treatment before use.
Scheme 4, the method of any of schemes 1-3, wherein the procyanidin content of the grape seed extract is above 95 wt.%.
Scheme 5, according to scheme 1-4 any preparation method, characterized in that, the fermentation substrate before inoculation is sterilized.
Scheme 6, the preparation method according to any one of schemes 1 to 5, wherein the mycelium volume percentage of the ganoderma lucidum liquid for inoculation to the fermentation substrate is 80% or more; the volume ratio of the bacterial liquid to the fermentation substrate is 1-10%.
Scheme 7, the preparation method according to any one of schemes 1 to 6, wherein the Ganoderma lucidum is Ganoderma lucidum (Ganoderma lucidum) strain wG055 with a collection number of CGMCC No. 17789.
Scheme 8 and the preparation method according to scheme 7 are characterized in that the preparation method of the bacterial liquid of the Ganoderma lucidum (ganoderam lucidum) strain wG055 sequentially comprises the following steps:
and (3) activation: inoculating the strain to glucose potato agar culture medium, activating at 23-28 deg.C for 3-7 days;
liquid culture: inoculating the single colony 2-3 rings obtained in the activation step into 100mL of glucose potato liquid culture medium for culture at the temperature of 23-28 ℃ for 3-7d at the rotation speed of 160-200rpm to obtain the bacterial liquid of the Ganoderma lucidum (Ganoderma lucidum) strain wG055 for inoculation.
Scheme 9, the preparation method according to any of schemes 1-8, characterized in that the temperature of the fermentation culture is 25-30 ℃ and the time is 3-7d, and the stirring treatment is carried out during the fermentation culture.
Scheme 10, the preparation method according to scheme 9, characterized in that the rotation speed of the stirring treatment is 100-200 rpm.
Scheme 11, the preparation method according to any one of schemes 1-10, characterized in that, the temperature of the sterilization treatment after the fermentation culture is 90-121 ℃, the time is 15-60 min.
Scheme 12 and the preparation method according to any one of schemes 1 to 11, wherein before the sterilization treatment, the separation treatment is further included, the precipitate is discarded, and the supernatant is taken to be subjected to the sterilization treatment, so that the ganoderma lucidum composite fermentation raw stock is finally obtained.
Scheme 13 and the preparation method according to any one of schemes 1 to 11, wherein the sterilization treatment further comprises separation treatment, sediment removal and supernatant fluid taking, and the ganoderma lucidum composite fermentation raw stock is finally obtained.
The production method according to claim 14, 12 or 13, wherein the separation treatment is a centrifugation treatment.
Scheme 15, the preparation method according to scheme 14, characterized in that, the speed of the centrifugal treatment is 3500-8000r/min, and the time is 20-60 min.
Scheme 16 and the preparation method according to any one of schemes 12 to 15, wherein the preparation method further comprises a drying treatment after the sterilization treatment, and finally the ganoderma lucidum composite fermented dry powder is obtained.
The method according to claim 17 or 16, wherein the drying treatment is spray drying or vacuum freeze drying.
Scheme 18, a ganoderma lucidum composite fermented dry powder prepared by the preparation method according to scheme 16 or 17.
Scheme 19, a ganoderma lucidum composite fermentation raw pulp prepared by the preparation method according to any one of schemes 12-15.
Scheme 20, the application of the ganoderma lucidum composite fermented dry powder in the aspect of preparing cosmetics according to scheme 18.
The application of the ganoderma lucidum composite fermentation protoplasm in the scheme 21 or the scheme 19 in the aspect of being used as or preparing cosmetics.
Finally, it is also noted that, in the present disclosure, relational terms such as first and second, and the like are used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising an … …" does not exclude the presence of other identical elements in a process, method, article, or apparatus that comprises the element.
While the disclosure has been disclosed above by the description of specific embodiments thereof, it should be understood that various modifications, improvements or equivalents of the disclosure may be devised by those skilled in the art within the spirit and scope of the appended claims. Such modifications, improvements and equivalents are intended to be included within the scope of the present disclosure as claimed.
Sequence listing
<110> Beijing university of Industrial and commercial
<120> firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof
<130> PD200215CN0284
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 646
<212> DNA
<213> Ganoderma lucidum (Ganoderma lucidum)
<400> 1
ccccttccgt agggtgaacc tgcggaagga tcattatcga gttttgaccg ggttgtagct 60
ggccttctga ggcatgtgca cgccctgttc atccactcta cacctgtgca cttactgtgg 120
gcttcagatt gcgaggcacg ctctttaccg ggcttgcgga gcatatctgt gcctgcgttt 180
atcacaaact ctataaagta acagaatgtg tattgcgatg taacacatct atatacaact 240
ttcagcaacg gatctcttgg ctctcgcatc gatgaagaac gcagcgaaat gcgataagta 300
atgtgaattg cagaattcag tgaatcatcg aatctttgaa cgcaccttgc gctccttggt 360
attccgagga gcatgcctgt ttgagtgtca tgaaatcttc aacctacaag cttttgtggt 420
ttgtaggctt ggacttggag gcttgtcggc cgttatcggt cggctcctct taaatgcatt 480
agcttggttc cttgcggatc ggctctcggt gtgataatgt ctacgccgtg accgtgaagc 540
gtttggcgag cttctaaccg tcttataaga cagctttatg acctctgacc tcaaatcagg 600
taggactacc cgctgaactt aagcatatca ataaagccgg aggaaa 646

Claims (10)

1. A preparation method of a skin-firming and nourishing ganoderma lucidum composite fermentation product is characterized by comprising the following steps: inoculating the ganoderma lucidum to a fermentation substrate consisting of poria cocos, oat, tremella, grape seed extract and water for fermentation culture, and then performing sterilization treatment to obtain the ganoderma lucidum composite fermentation product.
2. The preparation method according to claim 1, wherein in the fermentation substrate, the poria cocos is dry and is used in an amount of 0.01-1% by weight of water; the oat is oat bran powder, and the using amount of the oat bran powder is 0.01-0.2% of the mass of water; the tremella is dry and the amount of the tremella is 0.01-0.5% of the weight of water; the dosage of the grape seed extract is 0.01-0.05% of the weight of water.
3. The method of claim 2, wherein the poria cocos and the tremella fuciformis are subjected to crushing treatment before use.
4. The method according to any one of claims 1 to 3, wherein the extraction ratio of the grape seed extract is 4 to 20: 1.
5. The method according to any one of claims 1 to 4, wherein the fermentation substrate is sterilized before inoculation.
6. The method according to any one of claims 1 to 5, wherein the mycelia of the Ganoderma lucidum solution used for inoculation to the fermentation substrate is 80% by volume or more; the volume ratio of the bacterial liquid to the fermentation substrate is 1-10%.
7. The preparation method according to any one of claims 1 to 6, wherein the Ganoderma lucidum is Ganoderma lucidum (Ganoderma lucidum) strain wG055 with a collection number of CGMCC No. 17789.
8. The preparation method of claim 7, wherein the preparation method of the bacterial liquid of the Ganoderma lucidum (Ganoderma lucidum) strain wG055 sequentially comprises the following steps of:
and (3) activation: inoculating the strain to glucose potato agar culture medium, activating at 23-28 deg.C for 3-7 days;
liquid culture: inoculating the single colony 2-3 rings obtained in the activation step into 100mL of glucose potato liquid culture medium for culture at the temperature of 23-28 ℃ for 3-7d at the rotation speed of 160-200rpm to obtain the bacterial liquid of the Ganoderma lucidum (Ganoderma lucidum) strain wG055 for inoculation.
9. The method according to any one of claims 1 to 8, wherein the temperature of the fermentation culture is 25 to 30 ℃ and the time is 3 to 7 days, and the stirring treatment is performed during the fermentation culture.
10. The method as claimed in claim 9, wherein the rotation speed of the stirring process is 100-200 rpm.
CN202010930378.7A 2020-09-07 2020-09-07 Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof Pending CN113208976A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010930378.7A CN113208976A (en) 2020-09-07 2020-09-07 Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010930378.7A CN113208976A (en) 2020-09-07 2020-09-07 Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN113208976A true CN113208976A (en) 2021-08-06

Family

ID=77085989

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010930378.7A Pending CN113208976A (en) 2020-09-07 2020-09-07 Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN113208976A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115154385A (en) * 2022-07-19 2022-10-11 广西下班乐生物科技有限公司 Anti-aging mask and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044481A (en) * 1998-07-30 2000-02-15 Sunstar Inc Preparation for external use for skin
CN111454844A (en) * 2020-03-11 2020-07-28 北京工商大学 Novel ganoderma lucidum strain, ganoderma lucidum polysaccharide prepared based on ganoderma lucidum strain and anti-aging cosmetic

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044481A (en) * 1998-07-30 2000-02-15 Sunstar Inc Preparation for external use for skin
CN111454844A (en) * 2020-03-11 2020-07-28 北京工商大学 Novel ganoderma lucidum strain, ganoderma lucidum polysaccharide prepared based on ganoderma lucidum strain and anti-aging cosmetic

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王倩等: "碳氮比对真菌发酵桑枝-燕麦麸皮的活性成分和抗氧化能力的影响", 《食品工业科技》 *
王建新等: "《化妆品植物原料大全》", 30 June 2012 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115154385A (en) * 2022-07-19 2022-10-11 广西下班乐生物科技有限公司 Anti-aging mask and preparation method thereof

Similar Documents

Publication Publication Date Title
CN109893487B (en) Rice rose fermented raw pulp and preparation method and application thereof
CN106726949B (en) Grape seed fermentation raw stock cosmetic and preparation method and application thereof
CN113855603B (en) Combined fermentation product, skin external preparation containing same, and preparation method and application of combined fermentation product
CN110305920A (en) A kind of active fermentation object and its preparation method and application
CN113337545A (en) Schizophyllum commune fermentation product, preparation method thereof, skin care product and schizophyllum commune culture medium
CN109528568A (en) A kind of composition and preparation method thereof with anti-aging and white-skinned face function
CN113208954A (en) Anti-inflammatory and anti-aging ganoderma lucidum composite fermentation product and preparation method and application thereof
CN113208976A (en) Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof
Gou et al. Efficient production and skincare activity evaluation of schizophyllan, a β-glucan derived from Schizophyllum commune NTU-1
Wang et al. Composition analysis and prebiotics properties of polysaccharides extracted from Lepista sordida submerged cultivation mycelium
CN108486002B (en) Momordica grosvenori endophyte strain capable of producing exopolysaccharides, method for producing exopolysaccharides and application of exopolysaccharides
CN113559045A (en) Oat bran fermentation product, skin external preparation containing oat bran fermentation product, and preparation method and application of oat bran fermentation product
CN112245343B (en) Method for fermenting burdock root by lucid ganoderma, method for compositely fermenting burdock root, fermented product and application
CN113208978A (en) Rice-ganoderma lucidum composite fermentation product with functions of activating skin and resisting aging as well as preparation method and application of rice-ganoderma lucidum composite fermentation product
CN113208977A (en) Skin-activating and anti-aging ganoderma lucidum composite fermentation product and preparation method and application thereof
CN113208987A (en) Anti-aging and repairing rice ganoderma lucidum composite fermentation product and preparation method and application thereof
CN111956707A (en) Method for improving growth speed of saccharomyces cerevisiae and content of effective components in plants by using red light
CN115634241A (en) Preparation method of Shandong ganoderma lucidum extract and application of Shandong ganoderma lucidum extract in preparation of hypoglycemic drugs
CN113876614B (en) Glycyrrhizin and tremella aurantialba polysaccharide degradation product compound composition and application thereof
CN110638697B (en) Preparation and application of ganoderma lucidum lactobacillus fermentation extract
CN111374922B (en) Rice composite fermentation product and preparation method and application thereof
CN113288843A (en) Rice ganoderma lucidum composite fermentation product and preparation method and application thereof
WO2021217693A1 (en) Use of symbiotic fermentation product of hydrolyzed candida and japanese sake yeast
CN113208955A (en) Moisturizing and relieving ganoderma lucidum composite fermentation product and preparation method and application thereof
CN111544352A (en) Tremella-ganoderma lucidum composite fermentation product, cosmetic composition with anti-aging effect and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination